Gemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study.

El Serafi, Moustafa M

Gemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study. [electronic resource] - Journal of the Egyptian National Cancer Institute Sep 2006 - 209-15 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1110-0362


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Deoxycytidine--administration & dosage
Doxorubicin--administration & dosage
Female
Humans
Middle Aged
Treatment Outcome
Gemcitabine